These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27692192)

  • 1. Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.
    Lindblad R; Hu L; Oden N; Wakim P; Rosa C; VanVeldhuisen P
    J Subst Abuse Treat; 2016 Nov; 70():73-80. PubMed ID: 27692192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials.
    Hu L; Matthews A; Shmueli-Blumberg D; Killeen TK; Tai B; VanVeldhuisen P
    Drug Alcohol Depend; 2018 Sep; 190():255-262. PubMed ID: 30077926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
    Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A
    J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
    Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
    Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
    Marsch LA; Campbell A; Campbell C; Chen CH; Ertin E; Ghitza U; Lambert-Harris C; Hassanpour S; Holtyn AF; Hser YI; Jacobs P; Klausner JD; Lemley S; Kotz D; Meier A; McLeman B; McNeely J; Mishra V; Mooney L; Nunes E; Stafylis C; Stanger C; Saunders E; Subramaniam G; Young S
    J Subst Abuse Treat; 2020 Mar; 112S():4-11. PubMed ID: 32220409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.
    Greenfield SF; Rosa C; Putnins SI; Green CA; Brooks AJ; Calsyn DA; Cohen LR; Erickson S; Gordon SM; Haynes L; Killeen T; Miele G; Tross S; Winhusen T
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):301-12. PubMed ID: 21854272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.
    Susukida R; Crum RM; Stuart EA; Ebnesajjad C; Mojtabai R
    Addiction; 2016 Jul; 111(7):1226-34. PubMed ID: 26825855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment.
    Abraham AJ; Knudsen HK; Roman PM
    J Subst Abuse Treat; 2014 Feb; 46(2):232-7. PubMed ID: 24080073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders.
    Kelley AT; Incze MA; Baumgartner M; Campbell ANC; Nunes EV; Scharfstein DO
    Drug Alcohol Depend; 2024 Aug; 261():111368. PubMed ID: 38896944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience.
    Ghitza UE; Gore-Langton RE; Lindblad R; Shide D; Subramaniam G; Tai B
    Addiction; 2013 Jan; 108(1):3-8. PubMed ID: 22563741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and responding to trial implementation challenges during multisite clinical trials.
    Greer TL; Walker R; Rethorst CD; Northrup TF; Warden D; Horigian VE; Silverstein M; Shores-Wilson K; Stotts AL; Trivedi MH
    J Subst Abuse Treat; 2020 Mar; 112S():63-72. PubMed ID: 32220413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
    Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM;
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):283-93. PubMed ID: 21854270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.
    Tai B; Dobbins R; Blackeney Q; Liu D; Moran L
    Addict Sci Clin Pract; 2021 May; 16(1):28. PubMed ID: 33964973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.
    Susukida R; Crum RM; Ebnesajjad C; Stuart EA; Mojtabai R
    Addiction; 2017 Jul; 112(7):1210-1219. PubMed ID: 28191694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for safety reporting in substance abuse trials.
    Lindblad R; Campanella M; Styers D; Kothari P; Sparenborg S; Rosa C
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):440-5. PubMed ID: 21854288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality of treatment-seeking men and women with alcohol, opioid or other substance use disorders - A register-based follow-up study.
    Pitkänen T; Kaskela T; Levola J
    Addict Behav; 2020 Jun; 105():106330. PubMed ID: 32088539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.
    Campbell AN; Nunes EV; Miele GM; Matthews A; Polsky D; Ghitza UE; Turrigiano E; Bailey GL; VanVeldhuisen P; Chapdelaine R; Froias A; Stitzer ML; Carroll KM; Winhusen T; Clingerman S; Perez L; McClure E; Goldman B; Crowell AR
    Contemp Clin Trials; 2012 Mar; 33(2):386-95. PubMed ID: 22085803
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.